Weyerhaeuser Operating Cash Flow decreased by 75.2% to $52.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 25.7%, from $70.00M to $52.00M. Over 3 years (FY 2021 to FY 2024), Operating Cash Flow shows a downward trend with a -31.7% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.31B | $659.00M | $494.00M | $957.00M | $1.15B | $562.00M | $167.00M | $126.00M | $496.00M | $523.00M | $288.00M | $124.00M | $432.00M | $234.00M | $218.00M | $70.00M | $396.00M | $210.00M | $52.00M |
| QoQ Change | — | -49.6% | -25.0% | +93.7% | +19.7% | -51.0% | -70.3% | -24.6% | +293.7% | +5.4% | -44.9% | -56.9% | +248.4% | -45.8% | -6.8% | -67.9% | +465.7% | -47.0% | -75.2% |
| YoY Change | — | — | — | — | -12.4% | -14.7% | -66.2% | -86.8% | -56.7% | -6.9% | +72.5% | -1.6% | -12.9% | -55.3% | -24.3% | -43.5% | -8.3% | -10.3% | -25.7% |